Bayer | BAYN - Ebit

Aktienkurs
36.29
Täglich Wechseln
-1.49 -3.93%
Monatlich
-21.59%
Jährlich
56.09%
Q1 Prognose
40.79




Ebit Veränderung Datum
Air Liquide EUR 2.84B 6.65B 2025-12
Akzo Nobel EUR 217M 80M 2025-12
Alcon AG USD 317M 17M 2025-12
Amarin USD -1.7M 8.47M 2025-09
Arkema EUR 25M 82M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BASF EUR -175M 668M 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Beiersdorf EUR 504M 312M 2025-12
Corteva USD 811M 1.08B 2025-12
Covestro EUR -324M 5.72B 2025-12
Essilor EUR 1.38B 626M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Genmab DKK 432M 900.27M 2025-06
Givaudan CHF 756M 221M 2024-06
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Henkel EUR 1.61B 73M 2025-06
Hikma Pharmaceutical USD 348M 31M 2025-12
Johnson Matthey GBP 142M 89M 2025-12
Linde USD 2.42B 11M 2025-09
Lonza CHF 673M 54M 2025-06
Merck EUR 1.21B 180M 2025-09
Novartis USD -9.19B 13.87B 2025-06
Nutrien USD 704M 88M 2025-12
Philips EUR 719M 390M 2025-12
PPG Industries USD 450M 171M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
SAP EUR 2.78B 1.95B 2025-12
Solvay EUR 60M 27M 2025-12
UCB EUR 502M 168M 2024-12
Umicore EUR 304.3M 67.3M 2025-06
Vinci EUR 6.05B 2.25B 2025-12